Beckley Psytech's investors want to put more money into the psychedelics company at a $200 million valuation

Source: Business Insider

Eugene Mymrin/Getty ImagesA Beckley Psytech investor is looking to invest up to an extra $20 million in the biotech startup. Noetic Fund wants to back Beckley Psytech at a $200 million valuation, per an email seen by BI. The startup is developing a psychedelic-based nasal spray to treat depression.